S52 The Hormonal Aspects of Sleep Apnea

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 8:15 AM-9:45 AM
Room 104 (BCEC)
Developed in Collaboration with NHLBI and NIDDK
Chairs:
Michael J Twery, PhD, National Heart Lung and Blood Institute/NIH, Bethesda, and Corinne M. Silva, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/NIH, Bethesda, MD

Nothing to Disclose: MJT, CMS
8:15 AM
Peter Y Liu, MBBS, PhD, Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA
Nothing to Disclose: PYL
8:45 AM
Francesca Facco, MD, Dept. of Obstetrics and Gynecology, Magee-Womens Hospital, Pittsburgh, PA
Nothing to Disclose: FF
9:00 AM
Esra Tasali, MD, Department of Medicine, Section of Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, IL
Nothing to Disclose: ET
9:15 AM
Hadine Joffe, MD, MSc, Psychiatry, Brigham and Women's Hospital, Dana Farber Cancer Institute, & Harvard Medical School, Boston, MA
Disclosures:
HJ: Investigator, Merck & Co., Advisory Group Member, Merck & Co., Ad Hoc Consultant, Noven, Ad Hoc Consultant, Mitsubishi-Tanabe, Investigator, Teva.
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire